Charles P. Neff, Ph.D.

Affiliations: 
2011 Cell and Molecular Biology (Graduate Degree Program) Colorado State University, Fort Collins, CO 
Area:
Virology Biology, Cell Biology, Microbiology Biology
Google:
"Charles Neff"

Parents

Sign in to add mentor
Ramesh K. Akkina grad student 2011 Colorado State
 (Evaluation of novel therapeutics for HIV prevention and treatment in a humanized mouse model.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Burkhart Colorado AS, Lazzaro A, Neff CP, et al. (2024) Differential effects of antiretroviral treatment on immunity and gut microbiome composition in people living with HIV in rural versus urban Zimbabwe. Microbiome. 12: 18
Lazzaro A, Colorado ASB, Neff CP, et al. (2023) Antiretroviral treatment is less effective at reducing gut microbiome-associated inflammation and T cell activation in people living with HIV in rural versus urban Zimbabwe. Research Square
Littlefield KM, Schneider JM, Neff CP, et al. (2022) Elevated inflammatory fecal immune factors in men who have sex with men with HIV associate with microbiome composition and gut barrier function. Frontiers in Immunology. 13: 1072720
Neff CP, Atif SM, Logue EC, et al. (2020) HIV Infection Is Associated with Loss of Anti-Inflammatory Alveolar Macrophages. Journal of Immunology (Baltimore, Md. : 1950)
Siebert JC, Neff CP, Schneider JM, et al. (2019) VOLARE: visual analysis of disease-associated microbiome-immune system interplay. Bmc Bioinformatics. 20: 432
Li SX, Sen S, Schneider JM, et al. (2019) Gut microbiota from high-risk men who have sex with men drive immune activation in gnotobiotic mice and in vitro HIV infection. Plos Pathogens. 15: e1007611
Neff CP, Krueger O, Xiong K, et al. (2018) Fecal Microbiota Composition Drives Immune Activation in HIV-infected Individuals. Ebiomedicine. 30: 192-202
Hu S, Neff CP, Kumar DM, et al. (2016) A humanized mouse model for HIV-2 infection and efficacy testing of a single-pill triple-drug combination anti-retroviral therapy. Virology. 501: 115-118
Li SX, Armstrong AJ, Neff CP, et al. (2016) Complexities of gut microbiome dysbiosis in the context of HIV infection and antiretroviral therapy. Clinical Pharmacology and Therapeutics
Akhmetzyanova I, Drabczyk M, Neff CP, et al. (2015) Correction: PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing. Plos Pathogens. 11: e1005364
See more...